Theravance Biopharma Inc at JPMorgan Healthcare Conference Transcript
Hi, good morning. My name is Viviana Limon. I'm with the JPMorgan healthcare investment banking team. Thank you all for joining us today. It's my pleasure to introduce to you, Rick Winningham, Chairman and CEO of Theravance Biopharma. He'll be presenting to you today.
Good morning. I'd like to thank JPMorgan for inviting us here to present today, and I look forward to just talking about Theravance and our strategy and objectives going forward.
Very simply, while you've listened to a number of companies over the week talk about the treatment for serious diseases, I don't think you'll hear another company talk about transforming the treatment of serious diseases through discovery, development and commercialization of organ-selective medicines. And I don't believe that you'll listen to another company that's actually been successful at discovering and developing, commercializing a medicine for a serious disease that
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |